Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by W. G. Dixon
Influence of Anti-Tumor Necrosis Factor Therapy on Cancer Incidence in Patients With Rheumatoid Arthritis Who Have Had a Prior Malignancy: Results From the British Society for Rheumatology Biologics Register
Arthritis Care and Research
Rheumatology
Related publications
Biologic Refractory Disease in Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Venous Thrombotic Events Are Not Increased in Patients With Rheumatoid Arthritis Treated With Anti-TNF Therapy: Results From the British Society for Rheumatology Biologics Register
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Examining Changes in Central and Peripheral Pain as Mediates of Fatigue Improvement: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
Arthritis Care and Research
Rheumatology
Safety of Tumor Necrosis Factor Inhibitor Therapy in Patients With a Prior Malignancy
International Journal of Rheumatic Diseases
Rheumatology
Anti-TNF Therapies and Pregnancy: Outcome of 130 Pregnancies in the British Society for Rheumatology Biologics Register
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Malignancy Risk in Australian Rheumatoid Arthritis Patients Treated With Anti-Tumour Necrosis Factor Therapy: Analysis of the Australian Rheumatology Association Database (ARAD) Prospective Cohort Study
BMC Musculoskeletal Disorders
Rheumatology
Orthopedics
Sports Medicine
PMS73 Visualizing Treatment Patterns of Veteran Patients With Rheumatoid Arthritis Who Initiated Tumor Necrosis Factor Therapy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Tumor Necrosis Factor Α Antagonists in the Treatment of the Patients With Rheumatoid Arthritis
Reumatologia
Rheumatology
Allergy
Immunology
PMS9 Biologic Therapy Patterns and Associated Costs in Rheumatoid Arthritis Patients Who Initiated a Tumor Necrosis Factor Antagonist Over Two Years
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental